Abiopharma

🔍 Westerhold Mary (Director)

Company: FIRST MID BANCSHARES, INC. (FMBH)

Report Date: 2026-04-02

Detailed Transactions and Holdings:

• Acquired 323 shares of Common Stock at $41.15 per share (Direct)
  Date: 2026-04-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 15,278.87 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-02 | Code: H | nature_of_ownership: By IRA | shares_owned_after: 1,960.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-02 | Code: H | nature_of_ownership: By LLC 1 | shares_owned_after: 50,236.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-02 | Code: H | nature_of_ownership: By LLC 2 | shares_owned_after: 56,224.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-02 | Code: H | nature_of_ownership: by LLC 3 | shares_owned_after: 129,869.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-02 | Code: H | nature_of_ownership: By Spouse's IRA
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-02 | Code: H | nature_of_ownership: By Trusts 1 | shares_owned_after: 45,892.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-02 | Code: H | nature_of_ownership: By Trusts 2 | shares_owned_after: 16,454.00 | Footnotes: F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-02 | Code: H | shares_owned_after: 3,675.00

Footnotes:

• F1: The shares were acquired via the planned quarterly purchase under the Company's Deferred Compensation Plan.
• F2: Reflects transactions not required to be reported pursuant to Section 16 of the Securities Exchange Act of 1934, as amended
• F3: The reporting person is a co-manager of the LLC.
• F4: The reporting person is a co-trustee of these trusts, and the members of her immediate family are beneficiaries of the trusts. The reporting person disclaims beneficial ownership of the common stock held by the trusts except to the extent of her pecuniary interest therein.